8-KEarnings & ResultsExhibits & Filings

JOHNSON & JOHNSON 8-K Report, Financial Results (Jul 17, 2012)

Filed July 17, 2012For Securities:JNJ

Summary

Johnson & Johnson (JNJ) filed an 8-K on July 17, 2012, to report its second-quarter financial results for the period ended July 1, 2012. The filing primarily consists of a press release and supplementary financial data, providing investors with a snapshot of the company's performance during the quarter. Key details would be found within the attached press release and supplementary statements, which are the core components of this report.

Key Highlights

  • 1JNJ announced its second-quarter 2012 financial results on July 17, 2012.
  • 2The reporting period covers the second quarter ended July 1, 2012.
  • 3The 8-K filing includes a press release detailing sales and earnings.
  • 4Unaudited comparative supplementary sales data and condensed consolidated statements of earnings are provided.
  • 5This filing serves as the official disclosure of JNJ's quarterly financial performance.
  • 6Investors can find detailed operational and financial condition information within the attached exhibits.

Frequently Asked Questions

The primary purpose of this 8-K filing is to officially announce and provide Johnson & Johnson's second-quarter 2012 financial results, including sales and earnings, to the public and investors.

The specific financial results, including sales and earnings for the second quarter ended July 1, 2012, are detailed in the press release (Exhibit 99.15) and the unaudited comparative supplementary sales data and condensed consolidated statement of earnings (Exhibit 99.2O) attached to this 8-K filing.

Investors should look for key financial metrics such as total sales, net earnings, earnings per share (EPS), segment sales performance (e.g., Pharmaceuticals, Medical Devices, Consumer Health), and any commentary on the drivers of these results provided in the press release.

While this filing announces past results, the attached press release may contain forward-looking statements or management commentary discussing the company's performance and outlook. Investors should carefully review the press release for these insights.